Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donors After Reduced-intensity Conditioning: a Phase II Randomized Study Comparing 2 GVHD Prophylaxis Regimens
Sponsor: AZ Delta
A PHASE2 clinical study on Graft-Versus-Host Disease and Hematological Malignancies, this trial is ongoing. The trial is conducted by AZ Delta and has accumulated 13 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Sep 2022 — Jun 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 8 earlier versions
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
-
Oct 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Jul 2020 [monthly]
Recruiting PHASE2
-
Nov 2018 — Jun 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AZ Delta
- AZ Sint-Jan AV
- AZ-VUB
- Cliniques Universitaires de Mont-Godinne
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Hospital de Jolimont
- Jules Bordet Institute
- University Hospital, Antwerp
- University Hospital, Gasthuisberg
- University Hospital, Ghent
- University of Liege
- Ziekenhuis Netwerk Antwerpen (ZNA)
For direct contact, visit the study record on ClinicalTrials.gov .